Eizo Nanao Technologies unveiled its latest high-resolution flat-panel displays for medical imaging at the Comdex Fall 2001 show earlier this month. The new FlexScan monitors, FC-2090 gray-scale and FA-2090 color 20.8-inch flat-panel displays, come with
Eizo Nanao Technologies unveiled its latest high-resolution flat-panel displays for medical imaging at the Comdex Fall 2001 show earlier this month. The new FlexScan monitors, FC-2090 gray-scale and FA-2090 color 20.8-inch flat-panel displays, come with monitor, dual-head video card, and video cabling. Resolution is 2048 x 1536 with 170 viewing angles and a pixel pitch of 0.207. Eizo Nanao Technologies is the North American subsidiary of Eizo Nanao Corp., a leading Japanese manufacturer of CRT, LCD, and plasma displays.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.
Emerging MRI Scoring System May Help Predict Recurrent and Metastatic Hepatocellular Carcinoma
February 12th 2025Preoperative use of the scoring system for gadoxetic acid-enhanced MRI demonstrated an average AUC of 85 percent and average specificity of 89 percent in external validation cohorts for pathologic features of hepatocellular carcinoma.
Key Chest CT Parameters for Body Composition May be Prognostic for Patients with Resectable NSCLC
February 11th 2025A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.